Cost Effectiveness of Infant Vaccination for Rotavirus in Canada

Cost Effectiveness of Infant Vaccination for Rotavirus in Canada

INTRODUCTION: Rotavirus is the main cause of gastroenteritis in Canadian children younger than five years of age, resulting in significant morbidity and cost. The present study provides evidence on the cost effectiveness of two alternative rotavirus vaccinations (RotaTeq [Merck Frosst Canada Ltd, Ca...

Full description

Bibliographic Details
Main Authors: Doug Coyle, Kathryn Coyle, Julie A Bettinger, Scott A Halperin, Wendy Vaudry, David W Scheifele, Nicole Le Saux
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2012/327054
id doaj-957780dd455b42ad9344a1e8c089e8e5
record_format Article
spelling doaj-957780dd455b42ad9344a1e8c089e8e52021-07-02T01:39:37ZengHindawi LimitedCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322012-01-01232717710.1155/2012/327054Cost Effectiveness of Infant Vaccination for Rotavirus in CanadaDoug Coyle0Kathryn Coyle1Julie A Bettinger2Scott A Halperin3Wendy Vaudry4David W Scheifele5Nicole Le Saux6Department of Epidemiology and Community Medicine, University of Ottawa, CanadaApplied Health Economics Research Unit, Ottawa, Ontario, CanadaVaccine Evaluation Center, BC Children’s Hospital, Vancouver, British Columbia, CanadaCanadian Center for Vaccinology, IWK Health Centre, Dalhousie University, Halifax, Nova Scotia, CanadaStollery Children’s Hospital, Edmonton, Alberta, CanadaVaccine Evaluation Center, BC Children’s Hospital, Vancouver, British Columbia, CanadaChildren’s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, CanadaINTRODUCTION: Rotavirus is the main cause of gastroenteritis in Canadian children younger than five years of age, resulting in significant morbidity and cost. The present study provides evidence on the cost effectiveness of two alternative rotavirus vaccinations (RotaTeq [Merck Frosst Canada Ltd, Canada] and Rotarix [GlaxoSmithKline, Canada]) available in Canada.http://dx.doi.org/10.1155/2012/327054
collection DOAJ
language English
format Article
sources DOAJ
author Doug Coyle
Kathryn Coyle
Julie A Bettinger
Scott A Halperin
Wendy Vaudry
David W Scheifele
Nicole Le Saux
spellingShingle Doug Coyle
Kathryn Coyle
Julie A Bettinger
Scott A Halperin
Wendy Vaudry
David W Scheifele
Nicole Le Saux
Cost Effectiveness of Infant Vaccination for Rotavirus in Canada
Canadian Journal of Infectious Diseases and Medical Microbiology
author_facet Doug Coyle
Kathryn Coyle
Julie A Bettinger
Scott A Halperin
Wendy Vaudry
David W Scheifele
Nicole Le Saux
author_sort Doug Coyle
title Cost Effectiveness of Infant Vaccination for Rotavirus in Canada
title_short Cost Effectiveness of Infant Vaccination for Rotavirus in Canada
title_full Cost Effectiveness of Infant Vaccination for Rotavirus in Canada
title_fullStr Cost Effectiveness of Infant Vaccination for Rotavirus in Canada
title_full_unstemmed Cost Effectiveness of Infant Vaccination for Rotavirus in Canada
title_sort cost effectiveness of infant vaccination for rotavirus in canada
publisher Hindawi Limited
series Canadian Journal of Infectious Diseases and Medical Microbiology
issn 1712-9532
publishDate 2012-01-01
description INTRODUCTION: Rotavirus is the main cause of gastroenteritis in Canadian children younger than five years of age, resulting in significant morbidity and cost. The present study provides evidence on the cost effectiveness of two alternative rotavirus vaccinations (RotaTeq [Merck Frosst Canada Ltd, Canada] and Rotarix [GlaxoSmithKline, Canada]) available in Canada.
url http://dx.doi.org/10.1155/2012/327054
work_keys_str_mv AT dougcoyle costeffectivenessofinfantvaccinationforrotavirusincanada
AT kathryncoyle costeffectivenessofinfantvaccinationforrotavirusincanada
AT julieabettinger costeffectivenessofinfantvaccinationforrotavirusincanada
AT scottahalperin costeffectivenessofinfantvaccinationforrotavirusincanada
AT wendyvaudry costeffectivenessofinfantvaccinationforrotavirusincanada
AT davidwscheifele costeffectivenessofinfantvaccinationforrotavirusincanada
AT nicolelesaux costeffectivenessofinfantvaccinationforrotavirusincanada
_version_ 1721344644183228416

Similar Items